Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-09 Sale | 2024-01-11 5:06 pm | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 4,000 | $15.19 | $60,751 | 11,114 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-08 Tax Withholding | 2024-11-12 09:37 am | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 524 | $6.27 | 24,456 (Direct) | View |
| 2024-11-08 Exercise | 2024-11-12 09:37 am | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,785 | $0 | 24,456 (Direct) | View |
| 2024-11-01 Tax Withholding | 2024-11-05 8:30 pm | N/A N/A | OptimizeRx Corp | OPRX | Greco Theresa Chief Commercial Officer | 1,693 | $5.15 | 35,345 (Direct) | View |
| 2024-10-11 Exercise | 2024-10-15 4:53 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 8,222 | $0 | 33,366 (Direct) | View |
| 2024-10-11 Tax Withholding | 2024-10-15 4:53 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 2,066 | $6.63 | 33,366 (Direct) | View |
| 2024-10-03 Exercise | 2024-10-07 9:30 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 16,622 | $0 | 43,793 (Direct) | View |
| 2024-10-03 Tax Withholding | 2024-10-07 9:30 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 4,177 | $7.83 | 43,793 (Direct) | View |
| 2024-10-03 Exercise | 2024-10-07 9:26 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 6,649 | $0 | 29,844 (Direct) | View |
| 2024-10-03 Tax Withholding | 2024-10-07 9:26 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,952 | $7.83 | 29,844 (Direct) | View |
| 2024-10-03 Exercise | 2024-10-07 9:24 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 6,649 | $0 | 83,527 (Direct) | View |
| 2024-10-03 Tax Withholding | 2024-10-07 9:24 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 2,617 | $7.83 | 83,527 (Direct) | View |
| 2024-10-03 Exercise | 2024-10-07 9:24 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 3,324 | $0 | 13,521 (Direct) | View |
| 2024-10-03 Tax Withholding | 2024-10-07 9:24 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 976 | $7.83 | 13,521 (Direct) | View |
| 2024-08-02 Option Award | 2024-08-05 5:22 pm | 2025-08-02 2027-08-02 | OptimizeRx Corp | OPRX | McCarthy Brian Clark Chief Revenue Officer | 28,210 | $0 | 28,210 (Direct) | View |
Ownership | 2024-08-05 4:57 pm | N/A N/A | OptimizeRx Corp | OPRX | McCarthy Brian Clark Chief Revenue Officer | 0 | $0 | 0 (Direct) | View |
| 2024-04-18 Exercise | 2024-06-12 11:41 am | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 28,895 | $0 | 639,043 (Direct) | View |
| 2024-04-18 Tax Withholding | 2024-06-12 11:41 am | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 782 | $9.35 | 639,043 (Direct) | View |
| 2024-06-05 Exercise | 2024-06-11 5:50 pm | N/A N/A | OptimizeRx Corp | OPRX | Spangler Patrick D Director | 10,061 | $0 | 45,467 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 5:50 pm | N/A N/A | OptimizeRx Corp | OPRX | Spangler Patrick D Director | 13,286 | $0 | 45,467 (Direct) | View |
| 2024-06-05 Exercise | 2024-06-11 5:49 pm | N/A N/A | OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director | 10,061 | $0 | 62,774 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 5:49 pm | N/A N/A | OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director | 13,286 | $0 | 62,774 (Direct) | View |
| 2024-06-05 Exercise | 2024-06-11 5:48 pm | N/A N/A | OptimizeRx Corp | OPRX | WASSON GREGORY D Director | 10,061 | $0 | 47,315 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 5:48 pm | N/A N/A | OptimizeRx Corp | OPRX | WASSON GREGORY D Director | 13,286 | $0 | 47,315 (Direct) | View |
| 2024-06-05 Exercise | 2024-06-11 5:48 pm | N/A N/A | OptimizeRx Corp | OPRX | HALAS GUS D Director | 10,061 | $0 | 80,926 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 5:47 pm | N/A N/A | OptimizeRx Corp | OPRX | KLEMA CATHY Director | 6,643 | $0 | 6,643 (Direct) | View |
| 2024-06-05 Exercise | 2024-06-11 5:46 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 10,061 | $0 | 68,044 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 5:46 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 13,286 | $0 | 68,044 (Direct) | View |
| 2024-05-02 Exercise | 2024-05-06 9:35 pm | 2024-05-02 2024-05-02 | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 90,000 | $0 | 72,846 (Direct) | View |
| 2024-05-02 Tax Withholding | 2024-05-06 9:35 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 35,415 | $10.7 | 72,846 (Direct) | View |
| 2024-03-01 Exercise(A) | 2024-05-06 9:34 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 1,927 | $0 | 18,261 (Direct) | View |
| 2024-03-01 Tax Withholding(A) | 2024-05-06 9:34 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 572 | $15.95 | 18,261 (Direct) | View |
| 2024-02-15 Option Award(A) | 2024-05-06 9:32 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 7,750 | $0 | 16,906 (Direct) | View |
| 2024-02-15 Option Award | 2024-04-24 10:20 am | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 15,000 | $0 | 553,144 (Direct) | View |
| 2024-02-15 Option Award | 2024-04-24 10:18 am | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 4,000 | $0 | 7,848 (Direct) | View |
| 2024-02-15 Option Award | 2024-04-24 10:17 am | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 4,267 | $0 | 18,498 (Direct) | View |
| 2024-02-15 Option Award | 2024-04-24 10:16 am | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 7,083 | $0 | 14,765 (Direct) | View |
| 2024-03-15 Option Award | 2024-04-24 10:04 am | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 7,750 | $0 | 13,706 (Direct) | View |
| 2023-10-11 Exercise(A) | 2024-04-22 08:37 am | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 8,221 | $0 | 28,034 (Direct) | View |
| 2022-10-11 Tax Withholding(A) | 2024-04-22 08:31 am | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 3,539 | $15.17 | 7,682 (Direct) | View |
| 2024-04-15 Option Award | 2024-04-17 5:22 pm | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 60,000 | $0 | 538,144 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-06 4:20 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 1,927 | $0 | 7,884 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-06 4:20 pm | N/A N/A | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 668 | $15.95 | 7,884 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-06 4:19 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 771 | $0 | 15,002 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-06 4:19 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 268 | $15.95 | 15,002 (Direct) | View |
| 2023-12-19 Option Award | 2024-02-21 6:25 pm | N/A 2026-12-19 | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 11,784 | $0 | 11,784 (Direct) | View |
| 2023-12-19 Option Award | 2024-02-21 6:24 pm | N/A 2026-12-19 | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 31,422 | $0 | 31,422 (Direct) | View |
| 2023-12-19 Option Award | 2024-02-21 6:23 pm | 2024-12-19 2026-12-19 | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 23,566 | $0 | 23,566 (Direct) | View |
| 2023-12-19 Option Award | 2024-02-21 6:22 pm | N/A 2026-12-19 | OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer | 39,278 | $0 | 39,278 (Direct) | View |
| 2024-02-11 Exercise | 2024-02-13 6:16 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 4,000 | $0 | 29,728 (Direct) | View |
| 2024-02-11 Tax Withholding | 2024-02-13 6:16 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,386 | $15.39 | 29,728 (Direct) | View |
| 2024-02-02 Option Award | 2024-02-06 7:53 pm | N/A N/A | OptimizeRx Corp | OPRX | KLEMA CATHY Director | 5,109 | $0 | 5,109 (Direct) | View |
| 2024-01-09 Exercise | 2024-01-18 5:56 pm | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 9,628 | $0 | 478,144 (Direct) | View |
| 2024-01-09 Tax Withholding | 2024-01-18 5:56 pm | N/A N/A | OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO | 2,884 | $13.25 | 478,144 (Direct) | View |
| 2023-11-08 Exercise | 2023-11-13 2:32 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 1,785 | $0 | 16,899 (Direct) | View |
| 2023-11-08 Tax Withholding | 2023-11-13 2:32 pm | N/A N/A | OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO | 524 | $9.21 | 16,899 (Direct) | View |
| 2023-11-01 Option Award | 2023-11-03 10:49 am | N/A 2028-11-01 | OptimizeRx Corp | OPRX | Greco Theresa Chief Commercial Officer | 54,277 | $0 | 72,796 (Direct) | View |